Suppr超能文献

将药品的状态从处方药改为非处方药。

Changing the status of drugs from prescription to over-the-counter availability.

作者信息

Brass E P

机构信息

Department of Medicine, Harbor-UCLA Medical Center, Torrance, Calif 90502, USA.

出版信息

N Engl J Med. 2001 Sep 13;345(11):810-6. doi: 10.1056/NEJMra011080.

Abstract

The availability of drugs on an over-the-counter basis, including those previously available only by prescription, provides patients with improved access to effective therapies. Removal of the requirement for prescriptions saves both the health care professional and the patient time. However, the overall effect on health care costs is complex. One such effect may be that costs shift from third-party payers to patients. In addition, short-term cost savings may be offset over the long term by problems due to inappropriate use or suboptimal therapy. Optimal therapy with an over-the-counter drug requires that the consumer diagnose the underlying condition correctly and use the drug in a manner that minimizes risk. Assessment of the ability of patients to use drugs in this manner is a critical component of the regulatory review of over-the-counter drugs. The available data arouse the concern that without the supervision of a health care professional, some patients may not be able to use over-the-counter drugs appropriately for certain diagnoses or chronic conditions or in high-risk situations. On the other hand, the widespread use of over-the-counter aspirin on a long-term basis for cardiovascular-risk reduction illustrates the potential value of increased drug availability for long-term therapy. Advances in technology may facilitate the growth of over-the-counter drug therapy. For example, the wide availability and acceptance of reliable methods for measuring serum cholesterol in nonmedical settings may eventually contribute to the safety and effectiveness of over-the-counter treatments for hyperlipidemia. Thus, the future promises increases in the number of drugs available over the counter and in the variety of indications for their use.

摘要

非处方药的可得性,包括那些以前仅凭处方才能获得的药物,使患者能够更好地获得有效的治疗方法。取消处方要求为医疗保健专业人员和患者都节省了时间。然而,对医疗保健成本的总体影响是复杂的。其中一个影响可能是成本从第三方支付者转移到患者身上。此外,短期的成本节省可能会在长期内被不当使用或治疗不优化所带来的问题所抵消。使用非处方药进行最佳治疗要求消费者正确诊断潜在病症,并以将风险降至最低的方式使用药物。评估患者以这种方式使用药物的能力是对非处方药进行监管审查的关键组成部分。现有数据引发了人们的担忧,即如果没有医疗保健专业人员的监督,一些患者可能无法针对某些诊断、慢性病或高风险情况正确使用非处方药。另一方面,长期广泛使用非处方阿司匹林来降低心血管风险,说明了增加药物可得性对于长期治疗的潜在价值。技术进步可能会促进非处方药治疗的发展。例如,在非医疗环境中可靠的血清胆固醇测量方法的广泛可得性和接受度,最终可能有助于非处方降血脂治疗的安全性和有效性。因此,未来非处方药的数量及其使用适应症的种类有望增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验